1. Home >
  2. Companies >
  3. Public >
  4. Healthcare Services >
  5. China >
  6. Fosun Pharma >
  7. M&A

Fosun Pharma Mergers & Acquisitions

Fosun Pharma M&A Summary

Fosun Pharma has acquired 4 companies. A total of 3 acquisitions came from private equity firms. It has also divested 2 assets.

Fosun Pharma has acquired in 1 US state, and 4 countries. The Company’s most targeted sectors include life science (50%) and distribution (25%).

M&A Summary

  • M&A Total Activity5
    • M&A Buy Activity4
    • M&A Sell Activity1
  • Total Sectors Invested 3
  • Total Countries Invested 4
  • M&A Buy/Sell Connections 6

Fosun Pharma

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Building A No. 1289 Yishan Road Fosun Technology Park,
Shanghai, 200233
China,
+86 21 3398 7000
www.fosunpharma.com

All (5) Buy (4) Sell (1)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2021-06-18 Ambrx · Life Science
San Diego, California · www.ambrx.com

Ambrx is a clinical-stage biopharmaceutical company with a proprietary synthetic biology technology platform to design and develop next-generation antibody-drug conjugates (ADCs). The company is advancing a focused portfolio of clinical and preclinical programs designed to optimize efficacy and safety of its candidate therapeutics in multiple cancer indications, including ARX517, its proprietary ADC targeting PSMA for metastatic castration-resistant prostate cancer (mCRPC); ARX788, its proprietary ADC targeting human epidermal growth factor receptor 2 (HER2) for metastatic HER2+ breast cancer; and ARX305, its proprietary ADC targeting CD-70 for renal cell carcinoma. Ambrx was founded in 2003 and is based in San Diego, California.

- IPO -

DCP Capital (Dehong Capital) PE

HBM Partners PE

Fosun Pharma

WuXi AppTec

-

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal